Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

The latest news, stories and exciting findings from across the Oxford cancer research community

University's RadCam library highlighted in yellow

Experts gather for the second annual Oxford Oesophagogastric Cancer Centre of Excellence Symposium

Our second annual Oxford Oesophagogastric Cancer Centre of Excellence Symposium took place on Friday 6 March, bringing together researchers and clinicians from across Oxford alongside external collaborators for a stimulating day of multidisciplinary discussion.

Oesophagal adenocarcinoma section visualised by multiplexed immunofluorescence, showing cell nuclei (greyscale) and micronuclei (aberrant nuclear structures formed when chromosomes are improperly segregated during cell division; red) interspersed throughout the malignant cell compartment (cyan). Infiltrating macrophages are shown in yellow.

New research reveals why some oesophageal cancers are so hard to treat

Research published today in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping them to thrive.

Paresh Vyas receives CRUK Discovery Programme Award

Congratulations to Professor Paresh Vyas in the MRC Weatherall Institute of Molecular Medicine, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.

Professor Ester Hammond Awarded Brain Research UK Funding to Tackle Paediatric High-Grade Glioma

Ester Hammond, Professor of Molecular Cancer Biology in the Department of Oncology, has been awarded new funding from Brain Research UK to investigate much needed treatment options for paediatric high-grade glioma (pHGG), the most common cause of tumour-related death in children.

Bodlian Library Image

Oxford Researchers Join Global Cancer Grand Challenges Teams

Cancer Grand Challenges, a global initiative co-founded by the National Cancer Institute in the US and Cancer Research UK, today announced a major $125m commitment to propel cancer research into uncharted territory. Five pioneering international teams – two of which include researchers from the University of Oxford - will each receive up to $25m over approximately five years to tackle some of the most ambitious and unanswered questions in cancer.

Largest study of vegetarian diets and cancer shows lower risk of five cancers

The largest ever study of non-meat diets and cancer risk has found that vegetarian diets are associated with lower risks of several cancers ‒ breast, prostate, kidney and pancreatic cancers, and multiple myeloma ‒ but a higher risk of squamous cell carcinoma of the oesophagus.

Oxford Cancer Research Leadership Highlighted at CRUK’s Data-Driven Cancer Research Conference

Oxford University cancer researchers showcased cutting-edge data science and collaboration at Cancer Research UK’s 2026 Data-Driven Cancer Research Conference, reinforcing Oxford’s pivotal role in progressing CRUK’s research data strategy.

Early-phase study demonstrates safety and immune response of therapeutic HPV vaccine

An early-phase clinical trial led by Associate Professor Karin Hellner has reported results evaluating a new therapeutic vaccine designed to help the body clear high-risk human papillomavirus (HPV) infection in women with low-grade cervical lesions.

Close up shot of a corner of the old road campus research building

How Unstable Cancer Genomes Reshape the Tumour Landscape

Chromosomal instability (CIN) is a hallmark of aggressive cancers, yet the mechanisms through which it shapes tumour behaviour and clinical outcomes remain poorly defined. With new funding from Guts UK and the University of Oxford Medical Sciences Division, Dr Bruno Beernaert, postdoctoral researcher in the Department of Oncology, is tackling this challenge by developing innovative approaches to uncover the role of CIN in tumour evolution and immune evasion.

New trial on the Oxford Cancer Translational Data Platform

Through the Translational Data Platform, researchers can now access a rich collection of WINGMEN trial data, including patients demographics, cancer history, blood test results and biochemistry. Available datasets include RNA sequencing data from prostate tumours before and after treatment, alongside immunohistochemistry images assessing five key markers of prostate cancer biology, like IGF-R and pS6.

International Day of Women and Girls in Science: In conversation with Eva Hanlon

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from second-year Medical Undergraduate, Eva Hanlon, who is investigating the interplay between the immune system and tumour evolution in ovarian cancer

International Day of Women and Girls in Science: In conversation with Rebecca Ling

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from alumna Rebecca Ling, now a Clinical Postdoctoral Fellow working in Paediatric Haematology.

International Day of Women and Girls in Science: In conversation with Lena Duma

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from fourth-year Fundamental Scientist, Lena Duma, whose work in the Sir William Dunn School of Pathology focuses on a DNA repair system in cells in order to better understand how certain cancer treatments work.

International Day of Women and Girls in Science: In conversation with Hannah Baillie

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from third-year Fundamental Scientist, Hannah Baillie, who works in the Department of Chemistry investigating acute myeloid leukaemia, an aggressive type of blood cancer.

International Day of Women and Girls in Science: In conversation with Aglaia Skolariki

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from second-year Clinical Research Training Fellow, Aglaia Skolariki, whose DPhil examines how abnormal cell division in aggressive cancers drives particular genetic changes, and how these changes shape the immune system’s ability to recognise and respond to tumour cells.

International Day of Women and Girls in Science: In conversation with Safiyah Mohamed

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from first-year Fundamental Scientist Safiyah Mohamed, who is currently working in the Department of Clinical Neurosciences on research aiming to understand the biology of adult brain tumours.

International Day of Women and Girls in Science: In conversation with Jess Caterson

To mark International Day of Women and Girls in Science 2026, we interviewed several of our DPhil in Cancer Science students and alumnae to discuss what motivated them to pursue careers in cancer research. Hear from first-year Clinical Research Training Fellow Jess Caterson, who works at the Big Data Institute in the Nuffield Department of Population Health on research aiming to help modernise and digitalise surgical care through the use of wearable technology.

Photo of Sally Jeans alongside quote reading 'PPI is rewarding, fulfilling and gives you a sense of purpose. I feel that I am giving something back to the medical world that has helped me so much. '

[Video] Patient and Public Involvement with Oxford Cancer

The World Cancer Day theme 2025-2027 “United by Unique” places people at the centre of care and their stories at the heart of the conversation. At Oxford Cancer, we are committed to supporting Patient and Public Involvement (PPI) in research; we aim to build an inclusive community of PPI representatives who are involved in the design and delivery of cutting-edge cancer projects.

Treatment of tumours with sound: new high-intensity focused ultrasound machine installed

A new state-of-the-art high-intensity focused ultrasound (HIFU) machine has been installed at the Churchill Hospital, giving Oxford University Hospitals (OUH) cancer patients access to the latest in this innovative technology.

Oxford Cancer to launch innovative new funding scheme to support patient-led research ideas

Catriona Gilmour Hamilton, Oxford Cancer's Patient and Public Involvement (PPI) Manager, discusses our brand new PPI-Led Pump Priming Scheme, which will launch in Spring 2026.

Load More